New chemo combo may lower death risk in child stem cell transplants
NCT ID NCT02349906
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different chemotherapy drugs (Treosulfan and Busulfan) given before a stem cell transplant in 106 children with serious non-cancer diseases like immune disorders, metabolic diseases, blood disorders, and bone marrow failure. The goal was to see which drug leads to fewer deaths from transplant-related causes in the first 100 days. The approach uses a standard drug (Fludarabine) plus one of the two chemo drugs to prepare the body for donor stem cells.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE MARROW FAILURE SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Pediatric Oncology & Hematology, Charite Berlin
Berlin, 13353, Germany
-
Dzieciecy Szpital Kliniczny im. A. Gebali w Lublinie
Lublin, 20-093, Poland
-
Hannover Medical University, Dep. of Paediatrics, Paediatric Haematology and Oncology
Hanover, Germany
-
Heidelberg University Hospital
Heidelberg, 69120, Germany
-
Oncoematologia Pediatrica A.O. di Perugia Ospedale S. Maria della Misericordia
Perugia, 06156, Italy
-
Ospedale Bambino Gesu Roma
Rome, 00165, Italy
-
Ospedale Infantile Regina Margherita Torino
Turin, 10126, Italy
-
Reparto Trapianti Midollo Osseo Clinica Pediatrica Universitaria Fondazione MBBM-Ospedale San Gerardo
Monza, 20900, Italy
-
S.C. Oncoematologia Pediatrica Fondazione IRCCS Policlinico San Matteo
Pavia, 27100, Italy
-
SC Oncoematologia Pediatrica Ospedale Pediatrico Microcitemico "Antonio Cao" A.O. Brotzu
Cagliari, 09121, Italy
-
Szpital Uniwersytecki im. dr Antoniego Jurasza
Bydgoszcz, 85-094, Poland
-
U.O. Oncoematologia Pediatrica Azienda Ospedaliero Universitaria Pisana Ospedale S. Chiara
Pisa, 56100, Italy
-
U.O.C. Oncoematologia Pediatrica Policlinico "G.B. Rossi" - AOUI Verona
Verona, 37134, Italy
-
UOC Ematologia ed Oncologia Pediatrica con TMO AOU Policlinico Vittorio Emanuele
Catania, 95123, Italy
-
Ulm, University Hospital, Clinic for Children and Adolescents
Ulm, 89075, Germany
-
University Children's Hospital Essen Pediatric stem cell transplantation
Essen, 45122, Germany
-
University Hospital Frankfurt
Frankfurt am Main, 60590, Germany
-
University Hospital Motol, Dep. of Paediatric Haematology and Oncology
Prague, Czechia
-
University of Jena, Department of Pediatrics
Jena, 07747, Germany
-
Uniwersytecki Szpital Dzieciecy w Krakowie
Krakow, 30-663, Poland
-
Wroclaw Medical University, Department of Pediatric Hematology/Oncology and BMT
Wroclaw, 50-368, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug targets bone marrow failure
- Could a breath test replace blood draws for metabolic disease monitoring?
- New vitamin supplements aim to make life easier for kids with rare metabolic disorders
- New drug combo aims to make bone marrow transplants safer for kids
- Massive genetic study aims to unlock secrets of rare metabolic diseases
- New immune cell boost may shield kids from Post-Transplant infections